Log In
BCIQ
Print this Print this
 

MiSeqDx Cystic Fibrosis Clinical Sequencing Assay (MiSeqDx Cystic Fibrosis Diagnostic Assay)

  Manage Alerts
Collapse Summary General Information
Company Illumina Inc.
Descriptionin vivo assay that detects all mutations and variants within the CF transmembrane conductance regulator (CFTR) gene
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationPulmonary, Diagnostic
Indication DetailsDiagnose cystic fibrosis (CF) or congenital bilateral absence of vas deferens; Identify mutations in patients with suspected cystic fibrosis (CF)
Regulatory Designation U.S. - Undisclosed Review (Diagnose cystic fibrosis (CF) or congenital bilateral absence of vas deferens)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today